Volume 32 Issue 1

Review Article Efficacy of Bisphosphonate in Patients with Neurofibromatosis Type 1

Arzu Jalilova, Alessandra Cocca

J Bone Metab. 2025;32(1):1-10.

Original Articles Transforming Growth Factor-β Signaling Inhibits the Osteogenic Differentiation of Mesenchymal Stem Cells via Activation of Wnt/β-Catenin Pathway

Mahsa Tahoori, Azita Parvaneh Tafreshi, Fatemeh Naghshnejad, Bahman Zeynali

J Bone Metab. 2025;32(1):11-20.

Pharmacogenetics of Response to Bisphosphonate Treatment in Postmenopausal Osteoporosis: A Prospective Study

Sirin Akbulut Ayturk, Ozden Ozyemisci Taskiran, Ebru Koseoglu Tohma, Aylin Sepici Dincel, Nesrin Demirsoy, Vesile Sepici

J Bone Metab. 2025;32(1):21-30.

Generate Quantitative Computed Tomography-Equivalent Computed Tomography Image Interpretation Reports in Patients with Spinal Deformities

Hyunbin Kim, Hyeon Su Kim, Shinjune Kim, Jun-Il Yoo

J Bone Metab. 2025;32(1):31-37.

Incidence of Hypercalcemia and Vertebral Fractures Following Denosumab Withdrawal in Lung Cancer Patients: A Longitudinal Cohort Study

Marta Villanova, Sharon H. Chou, Le Min

J Bone Metab. 2025;32(1):38-48.

Treatment Goals for Prevention of Vertebral Fractures in Patients with Rheumatoid Arthritis

Takeshi Mochizuki, Mari Ando, Koichiro Yano, Ryo Hiroshima, Katsunori Ikari, Ken Okazaki

J Bone Metab. 2025;32(1):49-56.

Twenty-Year Trends in Osteoporosis Treatment and Post-Fracture Care in South Korea: A Nationwide Study

Kyoung Jin Kim, Kyoung Min Kim, Young-Kyun Lee, Jihye Kim, Hoyeon Jang, Jaiyong Kim, Ha Young Kim

J Bone Metab. 2025;32(1):57-66.

Letter to the Editor Calcium Supplementation: To Do or Not to Do

Emanuella Graciela Borges Fonseca, Carlos Marques dos Santos, Felipe Freire da Silva, Ana Tereza Amoedo Martinez, Jozélio Freire de Carvalho

J Bone Metab. 2025;32(1):67-68.